iPS Cell Differentiation for Tissue-Specific Genetic Variation Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods are inadequate for determining tissue-specific genetic variations, particularly in challenging cell types like retinal pigment epithelium cells, which are difficult to obtain and analyze, hindering the diagnosis and characterization of genetic diseases.
Innovation Solution
The use of induced pluripotent stem cells (iPS cells) to differentiate into specific cell types, such as retinal or cardiac muscle cells, allowing for the isolation and analysis of genetic material to identify tissue-specific genetic variations through sequencing and expression profiling.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If specific cell types are isolated directly from human subjects, then tissue-specific genetic variation can be analyzed, but it becomes difficult to obtain certain specialized cell types such as retinal pigment epithelium cells
Solution Approach 1:
The patent creates copies of specialized cells (such as retinal pigment epithelium cells) by differentiating induced pluripotent stem cells into the desired cell type. This allows researchers to obtain sufficient quantities of specific cell types for genetic analysis without the need to directly isolate rare cells from human subjects, thereby resolving the contradiction between analysis accuracy and cell availability.
2Ease of operation
If induced pluripotent stem cells are used to differentiate into specific cell types, then challenging cell types can be obtained for analysis, but the process complexity increases
Solution Approach 1:
The patent performs preliminary actions by first reprogramming somatic cells into induced pluripotent stem cells, which then serve as a versatile precursor for generating various specialized cell types. This preliminary step simplifies subsequent experiments, as the same iPS cell line can be differentiated into multiple cell types needed for comprehensive genetic analysis, reducing overall process complexity despite the initial reprogramming step.
3Measurement precision
If genetic material is analyzed in differentiated cells, then tissue-specific genetic defects can be identified, but the time required for cell differentiation increases
Solution Approach 1:
The patent performs preliminary genetic analysis on induced pluripotent stem cells before differentiation to identify obvious genetic defects early in the process. This preliminary screening reduces the time required, as not all iPS cell lines need to undergo the lengthy differentiation process if genetic abnormalities are already detected at the stem cell stage, thereby balancing time investment with diagnostic precision.
Data Source
AI summary
Methods for the determination of tissue-specific genetic variation are provided. For example, in certain aspects methods for using iPS cell-derived specific cell types for differential molecular analysis of tissue-specific genetic variation are described.